This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Keller, U. Articles by Stauffacher, W. Search for Related Content PubMed PubMed Citation Articles by Keller, U. Articles by Stauffacher, W. Social Bookmarking                         What's this?

Protein Metabolism Assessed by 1-13C Leucine Infusions in Patients Undergoing Bone Marrow Transplantation

Division of Endocrinology and Metabolism, Departments of Medicine and Research, University Hospital, Basel

M.E. Kraenzlin, M.D.

Division of Endocrinology and Metabolism, Departments of Medicine and Research, University Hospital, Basel

A. Gratwohl, M.D.

Division of Hematology, Departments of Medicine and Research, University Hospital, Basel

A. Thélin, B.Sc.

NESTEC Lab, Vers-chez-les-Blanc, Switzerland

E. Straumann, M.D.

Division of Endocrinology and Metabolism, Departments of Medicine and Research, University Hospital, Basel

M.J. Arnaud, PH.D.

NESTEC Lab, Vers-chez-les-Blanc, Switzerland

B. Speck, M.D.

Division of Endocrinology and Metabolism, Departments of Medicine and Research, University Hospital, Basel

W. Stauffacher, M.D.

Division of Endocrinology and Metabolism, Departments of Medicine and Research, University Hospital, Basel

Patients receiving cytoreductive therapy and bone marrow transplantation (BMT) are known to develop marked protein catabolism. To assess the contribution of whole body protein breakdown, amino acid oxidation and incorporation into proteins, plasma leucine kinetics (1-¹³C-leucine infusion technique) were determined in six patients five times within 14 days before and after cytoreductive therapy (Cyclophosphamide and total body irradiation) and marrow transplantation. Nitrogen balance became negative (—0.20 ± 0.04 g/ Kg/24 hr) after cyclophosphamide (p < 0.01) and was -0.25 ± 0.05 g/Kg/24 hr 7 days after BMT in spite of total parenteral nutrition.

Plasma leucine concentration increased after BMT by 67% (p < 0.0015). Leucine plasma appearance was 1.20 ± 0.15 µmol/ kg/min before treatment, it increased slightly and transiently after cyclophosphamide, and increased again from day 5 to day 7 after BMT (p < 0.01), suggesting increased protein breakdown. Leucine oxidation increased from 0.27 ± 0.07 before therapy to 0.97 ± 0.16 µmol/kg/min (p < 0.02) after cyclophosphamide and BMT. Nonoxidative leucine disappearance rate decreased slightly from 0.92 ± 0.08 to 0.75 ± 0.16 µmol/kg/min after BMT (ns). Leucine metabolic clearance rate decreased from 11.8 ± 1.65 before therapy to 6.9 ± 0.70 ml/kg/min (p < 0.02) after cytoreductive therapy. After BMT it increased again to 9.9 ± 1.5 ml/kg/min (p < 0.02). The results demonstrate that patients undergoing cytoreductive therapy and bone marrow transplantation develop negative nitrogen balance due to increased protein breakdown associated with increased leucine oxidation and increased metabolic clearance rate. Leucine incorporation into proteins (protein synthesis) was not altered inspite of an increase in plasma leucine concentration. ( Journal of Parenteral and Enteral Nutrition 14:480-484, 1990)

Journal of Parenteral and Enteral Nutrition, Vol. 14, No. 5, 480-484 (1990)
DOI: 10.1177/0148607190014005480


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				J. S. Scolapio, V. B. Tarrosa, G. L. Stoner, A. Moreno-Aspitia, L. A. Solberg Jr, and E. J. Atkinson Audit of Nutrition Support for Hematopoietic Stem Cell Transplantation at a Single Institution Mayo Clin. Proc., July 1, 2002; 77(7): 654 - 659. [Abstract] [PDF]

				T. W. Mattox Specialized Nutrition Management of Patients Receiving Hematopoietic Stem Cell Transplantation Nutr Clin Pract, February 1, 1999; 14(1): 5 - 15. [Abstract] [PDF]

				K. Ringwald-Smith, R. Williams, E. Horwitz, and M. Schmidt Determination of Energy Expenditure in the Bone Marrow Transplant Patient Nutr Clin Pract, October 1, 1998; 13(5): 215 - 218. [Abstract] [PDF]

				V. M. Herrmann and P. J. Petruska Nutrition Support in Bone Marrow Transplant Recipients Nutr Clin Pract, February 1, 1993; 8(1): 19 - 27. [Abstract] [PDF]